
Mrigank Dhaniwala
Articles
-
1 day ago |
gurutrade.com | Jaspreet Kalra |Mrigank Dhaniwala
MUMBAI, May 13 (Reuters) - The Indian rupee closed nearly flat on Tuesday as a fall in local equities and dollar bids from state-run banks ate into the currency's early gains spurred by the cessation of military hostilities between India and Pakistan. The rupee touched a peak of 84.6350 in early trading before ending at 85.33 against the U.S. dollar, nearly unchanged from its close at 85.37 on Friday.
-
3 days ago |
gurutrade.com | Kashish Tandon |Nivedita Bhattacharjee |Mrigank Dhaniwala
May 12 (Reuters) - Indian pharma stocks fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug prices by 30%–80% to match other wealthy nations. Trump said he would sign an executive order on Monday to pursue "most favored nation" pricing. The U.S. currently pays nearly three times more for many prescription drugs, though Trump offered no implementation details.
-
1 week ago |
today.westlaw.com | Abinaya Vijayaraghavan |Miyoung Kim |Nivedita Bhattacharjee |Mrigank Dhaniwala
(Reuters) -The U.S. Department of Justice has proposed that Google sell its AdX digital ad marketplace and DFP platform for managing and delivering ads on websites, after a federal judge found the company illegally dominated two online ad-tech...
-
1 week ago |
gurutrade.com | Sneha Kumar |Nivedita Bhattacharjee |Mrigank Dhaniwala
May 5 (Reuters) - Shares of Australia's Qantas Airways rose over 5% on Monday to a one-month high, tracking a drop in oil prices after OPEC+ signaled faster output hikes. Oil prices fell over $2 a barrel after OPEC+ agreed to boost output for a second straight month, despite sliding prices and weakening demand expectations. Jet fuel is a key cost for airlines, and falling prices raise hopes for improved profitability.
-
1 week ago |
today.westlaw.com | Nivedita Bhattacharjee |Pushkala Aripaka |Mrigank Dhaniwala
(Reuters) -AstraZeneca said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for uncontrolled asthma, showing clinically meaningful improvement in lung function.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →